Companion Animals

Companion Cat Arthritis and Solensia Treatment

Treatment of feline osteoarthritis with the monoclonal antibody Solensia and welfare implications for affected cats.

Key Facts

Osteoarthritis affects an estimated 40% of all cats and over 90% of cats over 10 years
Feline arthritis pain is significantly underdiagnosed due to cat stoicism
Solensia (frunevetmab) is a monoclonal antibody providing monthly pain relief
Clinical trials show significant improvement in mobility and owner-reported quality of life
Solensia targets nerve growth factor to interrupt pain signalling specifically

Welfare Considerations

Feline arthritis causes chronic pain that is widely underrecognised and undertreated, and Solensia represents a transformative treatment option that dramatically improves welfare for affected cats.

What You Can Do

Have elderly cats assessed for arthritis at every veterinary check-up
Ask your vet about Solensia if your cat shows mobility changes or reduced activity
Use feline pain assessment scales to monitor treatment response